Banks - Regional
Compare Stocks
2 / 10Stock Comparison
CARE vs NTRS
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
CARE vs NTRS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Asset Management |
| Market Cap | $580M | $30.26B |
| Revenue (TTM) | $255M | $14.30B |
| Net Income (TTM) | $31M | $1.74B |
| Gross Margin | 61.7% | 56.5% |
| Operating Margin | 15.7% | 16.3% |
| Forward P/E | 4.8x | 15.1x |
| Total Debt | $179M | $16.43B |
| Cash & Equiv. | $105M | $61.13B |
CARE vs NTRS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 370.7 | +270.7% |
| Northern Trust Corp… (NTRS) | 100 | 206.7 | +106.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NTRS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.56
- Rev growth 6.2%, EPS growth 32.1%
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
NTRS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 173.7% 10Y total return vs CARE's 111.1%
- Efficiency ratio 0.4% vs CARE's 0.5% (lower = leaner)
- 1.9% yield; 1-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.2% NII/revenue growth vs NTRS's -9.9% | |
| Value | Lower P/E (4.8x vs 15.1x) | |
| Quality / Margins | Efficiency ratio 0.4% vs CARE's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs NTRS's 1.14, lower leverage | |
| Dividends | 1.9% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +71.8% vs CARE's +68.4% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs CARE's 0.5% |
CARE vs NTRS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs NTRS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CARE leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NTRS is the larger business by revenue, generating $14.3B annually — 56.2x CARE's $255M. Profitability is closely matched — net margins range from 12.3% (CARE) to 12.1% (NTRS).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $255M | $14.3B |
| EBITDAEarnings before interest/tax | $46M | $3.2B |
| Net IncomeAfter-tax profit | $31M | $1.7B |
| Free Cash FlowCash after capex | $30M | $4.7B |
| Gross MarginGross profit ÷ Revenue | +61.7% | +56.5% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +16.3% |
| Net MarginNet income ÷ Revenue | +12.3% | +12.1% |
| FCF MarginFCF ÷ Revenue | +12.5% | +38.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +7.1% |
Valuation Metrics
NTRS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, NTRS trades at a 0% valuation discount to CARE's 18.7x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $580M | $30.3B |
| Enterprise ValueMkt cap + debt − cash | $653M | -$14.4B |
| Trailing P/EPrice ÷ TTM EPS | 18.69x | 18.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.76x | 15.10x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.89x |
| EV / EBITDAEnterprise value multiple | 16.33x | -4.49x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.12x |
| Price / BookPrice ÷ Book value/share | 1.40x | 2.38x |
| Price / FCFMarket cap ÷ FCF | 18.23x | 5.54x |
Profitability & Efficiency
NTRS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NTRS delivers a 13.4% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $8 for CARE. CARE carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to NTRS's 1.27x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs NTRS's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +13.4% |
| ROA (TTM)Return on assets | +0.7% | +1.0% |
| ROICReturn on invested capital | +5.7% | +6.0% |
| ROCEReturn on capital employed | +1.5% | +9.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.43x | 1.27x |
| Net DebtTotal debt minus cash | $73M | -$44.7B |
| Cash & Equiv.Liquid assets | $105M | $61.1B |
| Total DebtShort + long-term debt | $179M | $16.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.38x |
Total Returns (Dividends Reinvested)
NTRS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,800 today (with dividends reinvested), compared to $14,998 for NTRS. Over the past 12 months, NTRS leads with a +71.8% total return vs CARE's +68.4%. The 3-year compound annual growth rate (CAGR) favors NTRS at 33.2% vs CARE's 24.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +34.7% | +17.8% |
| 1-Year ReturnPast 12 months | +68.4% | +71.8% |
| 3-Year ReturnCumulative with dividends | +94.6% | +136.1% |
| 5-Year ReturnCumulative with dividends | +88.0% | +50.0% |
| 10-Year ReturnCumulative with dividends | +111.1% | +173.7% |
| CAGR (3Y)Annualised 3-year return | +24.8% | +33.2% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NTRS's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 99.1% from its 52-week high vs NTRS's 94.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.14x |
| 52-Week HighHighest price in past year | $26.41 | $173.19 |
| 52-Week LowLowest price in past year | $15.37 | $96.28 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +94.3% |
| RSI (14)Momentum oscillator 0–100 | 75.2 | 57.1 |
| Avg Volume (50D)Average daily shares traded | 273K | 1.1M |
Analyst Outlook
NTRS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CARE as "Buy" and NTRS as "Hold". Consensus price targets imply 3.2% upside for CARE (target: $27) vs -5.8% for NTRS (target: $154). NTRS is the only dividend payer here at 1.92% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $153.75 |
| # AnalystsCovering analysts | 4 | 35 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $3.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +4.2% |
NTRS leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). CARE leads in 2 (Income & Cash Flow, Risk & Volatility).
CARE vs NTRS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CARE or NTRS a better buy right now?
For growth investors, Carter Bankshares, Inc.
(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus -9. 9% for Northern Trust Corporation (NTRS). Northern Trust Corporation (NTRS) offers the better valuation at 18. 7x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NTRS?
On trailing P/E, Northern Trust Corporation (NTRS) is the cheapest at 18.
7x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CARE or NTRS?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +88. 0%, compared to +50. 0% for Northern Trust Corporation (NTRS). Over 10 years, the gap is even starker: NTRS returned +173. 7% versus CARE's +111. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NTRS?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus Northern Trust Corporation's 1. 14β — meaning NTRS is approximately 103% more volatile than CARE relative to the S&P 500. On balance sheet safety, Carter Bankshares, Inc. (CARE) carries a lower debt/equity ratio of 43% versus 127% for Northern Trust Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NTRS?
By revenue growth (latest reported year), Carter Bankshares, Inc.
(CARE) is pulling ahead at 6. 2% versus -9. 9% for Northern Trust Corporation (NTRS). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to -10. 5% for Northern Trust Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NTRS?
Carter Bankshares, Inc.
(CARE) is the more profitable company, earning 12. 3% net margin versus 12. 1% for Northern Trust Corporation — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTRS leads at 16. 3% versus 15. 7% for CARE. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NTRS more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 4. 8x forward P/E versus 15. 1x for Northern Trust Corporation — 10. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 2% to $27. 00.
08Which pays a better dividend — CARE or NTRS?
In this comparison, NTRS (1.
9% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NTRS better for a retirement portfolio?
For long-horizon retirement investors, Northern Trust Corporation (NTRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
14), 1. 9% yield, +173. 7% 10Y return). Both have compounded well over 10 years (NTRS: +173. 7%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NTRS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
NTRS pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.